Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Buy
101
+1
+1% +$252 0.01% 126
2026
Q1
$24K Hold
100
0.01% 112
2025
Q4
$29K Hold
100
0.01% 112
2025
Q3
$28K Hold
100
0.01% 111
2025
Q2
$29K Sell
100
-9
-8% -$2.32K 0.01% 108
2025
Q1
$27K Buy
109
+9
+9% +$2.2K 0.01% 110
2024
Q4
$21K Hold
100
0.01% 114
2024
Q3
$22K Hold
100
0.01% 111
2024
Q2
$17K Hold
100
0.01% 118
2024
Q1
$20K Hold
100
0.01% 119
2023
Q4
$16K Hold
100
0.01% 132
2023
Q3
$14K Hold
100
0.01% 99
2023
Q2
$13K Hold
100
0.01% 104
2023
Q1
$13K Hold
100
0.01% 103
2022
Q4
$14K Hold
100
0.01% 106
2022
Q3
$11K Hold
100
0.01% 104
2022
Q2
$14K Hold
100
0.01% 99
2022
Q1
$13K Hold
100
0.01% 104
2021
Q4
$13K Buy
+100
New +$12.5K 0.01% 87

Other funds holding IBM

Evolution Advisers's IBM Position: Q2 2026 in Review

Evolution Advisers increased its IBM (IBM) stake by 1% in Q2 2026, buying an estimated $252 and bringing the position to 101 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #126.

Evolution Advisers first reported a position in IBM in Q4 2021 and has held it in 19 quarters since. The position peaked at $29K in Q4 2025. 2,149 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Evolution Advisers held 101 shares of IBM worth $28K as of Q2 2026.
  • Evolution Advisers bought 1 IBM share in Q2 2026, an estimated $252.
  • IBM made up 0.01% of Evolution Advisers's portfolio in Q2 2026, its #126 holding.
  • Evolution Advisers first reported a position in IBM in Q4 2021 and has held it in 19 quarters since.
  • Evolution Advisers's IBM position peaked at $29K in Q4 2025.
  • 2,149 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.